Mechanism of inflammation-induced steroid resistance
Mechanism of inflammation-induced steroid resistance
批准号:
7301249
负责人:
OMAR TLIBA
金额:
$9.0万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-08-15 至 2009-07-31
关键词:
AccountingAddressAsthmaAwardBindingBinding SitesBiological AssayCell Adhesion MoleculesCell LineCellsCellular biologyCo-ImmunoprecipitationsDNA BindingDataDevelopmentDiseaseDominant-Negative MutationDoseEffector CellElectrophoretic Mobility Shift AssayElementsEnzyme-Linked Immunosorbent AssayFigs - dietaryFlow CytometryFractalkineFunctional disorderGRP geneGenesGlucocorticoid ReceptorGlucocorticoidsGoalsGrowth FactorHealthHealth Care CostsHourIRF1 geneImmuneInflammationInflammatoryInflammatory Bowel DiseasesInflammatory ResponseIntercellular adhesion molecule 1InterferonsKnowledgeLaboratoriesLeadLung diseasesMediatingMentorsMesenchymalMolecularPP5 protein-serine-threonine phosphatasePathogenesisPathway interactionsPatientsPennsylvaniaPharmacologyPhasePhosphoric Monoester HydrolasesPhosphorylationPlayPolymerase Chain ReactionPropertyProtein IsoformsProtein OverexpressionProtein Serine/Threonine PhosphataseProteinsPublic HealthRANTESRNA InterferenceRecruitment ActivityRegulationRelative (related person)ReporterResearchResearch PersonnelResistanceRoleSerineSignal TransductionSmooth Muscle MyocytesSteroid ReceptorsSteroid ResistanceSteroidsTechniquesTechnologyTestingTherapeuticTherapeutic AgentsThreonineTimeTissuesTransactivationTransfectionUniversitiesUp-RegulationWestern Blottingairway obstructionchemokinechromatin immunoprecipitationcytokinedesignexperienceglucocorticoid receptor betaglucocorticoid receptor-interacting protein 1human TIF2 factorimmunocytochemistryimprovedinhibitor/antagonistinsightnovelnovel therapeuticsnucleocytoplasmic transportprogramsrespiratory smooth muscleskillstherapeutic targettranscription factorvector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Although steroids are highly effective in the control of asthma, some patients fail to respond even to high doses. Steroid resistance is a veritable health challenge due to the absence of therapeutic alternatives and a financial burden as steroid-resistant patients account for more than 50% of asthma related healthcare costs. The candidate's current research at the University of Pennsylvania focuses in studying steroid resistance in airway smooth muscle (ASM), a tissue that is relevant for lung diseases. The short term goal of the studies performed currently and during the mentored phase of this award (K99) is to delineate the molecular mechanisms that underlay the diminished efficacy of steroids. This study will be pursued during the independent phase of this award (R00) with the ultimate objective to develop new therapeutic options to treat steroid-resistant asthmatics. The candidate's long term goal is to establish his own independent research program and submit an R01 application. The central hypothesis of this proposal is novel and states that pro-asthmatic cytokines impair steroid function in ASM cells through the coordinated activation of three pathways: (i) GR beta, a steroid receptor beta isoform that can act as an inhibitor of GC actions (will be addressed in Aim 1), (ii) IRF-1, a transcription factor that regulates many inflammatory genes (will be addressed in Aim 2), and (iii) Serine/threonine protein phosphatase 5 (PP5), shown to act as an inhibitor of steroid actions in different cell lines (will be addressed in Aim 3). All three Aims of the present proposal will rely on multiple complementary approaches such as siRNA technology, transfection of reporter vectors as well as over-expression of constitutively active or dominant negative proteins, co-immunoprecipitation and co-localization techniques, chromatin immunoprecipitation and gel shift assays. Subsequently, this award will dramatically enhance the candidate's technical skills and will broaden his expertise in molecular pharmacology and cell biology. We believe that our proposal is relevant to public health since improving the knowledge about the factors that lead to steroid resistance will help design new therapeutic agents or alternatives to treat steroid-resistant asthmatics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Airway Inflammatory Pathways Regulating Glucocorticoid Receptor Phosphorylation
-
批准号:10159949
-
项目类别:
-
资助金额:$9.27万
-
财政年份:2018
-
负责人:OMAR TLIBA
-
依托单位:
TRUSS as a novel regulator of inflammatory genes in asthma
-
批准号:8897989
-
项目类别:
-
资助金额:$23.25万
-
财政年份:2014
-
负责人:OMAR TLIBA
-
依托单位:
TRUSS as a novel regulator of inflammatory genes in asthma
-
批准号:8702540
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2014
-
负责人:OMAR TLIBA
-
依托单位:
Airway Inflammatory Pathways Regulating Glucocorticoid Receptor Phosphorylation
-
批准号:8427314
-
项目类别:
-
资助金额:$35.1万
-
财政年份:2012
-
负责人:OMAR TLIBA
-
依托单位:
Airway Inflammatory Pathways Regulating Glucocorticoid Receptor Phosphorylation
-
批准号:9424454
-
项目类别:
-
资助金额:$36.87万
-
财政年份:2012
-
负责人:OMAR TLIBA
-
依托单位:
Airway Inflammatory Pathways Regulating Glucocorticoid Receptor Phosphorylation
-
批准号:10622111
-
项目类别:
-
资助金额:$27.11万
-
财政年份:2012
-
负责人:OMAR TLIBA
-
依托单位:
Airway Inflammatory Pathways Regulating Glucocorticoid Receptor Phosphorylation
-
批准号:8625331
-
项目类别:
-
资助金额:$36.13万
-
财政年份:2012
-
负责人:OMAR TLIBA
-
依托单位:
Airway Inflammatory Pathways Regulating Glucocorticoid Receptor Phosphorylation
-
批准号:8220499
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2012
-
负责人:OMAR TLIBA
-
依托单位:
Mechanism of inflammation-induced steroid resistance
-
批准号:7486327
-
项目类别:
-
资助金额:$9.0万
-
财政年份:2007
-
负责人:OMAR TLIBA
-
依托单位:
Mechanisms of Steroid Resistance in Airway Smooth Muscle Cells
-
批准号:7753874
-
项目类别:
-
资助金额:$24.87万
-
财政年份:2007
-
负责人:OMAR TLIBA
-
依托单位:
Mechanisms of Steroid Resistance in Airway Smooth Muscle Cells
-
批准号:7684321
-
项目类别:
-
资助金额:$24.42万
-
财政年份:2007
-
负责人:OMAR TLIBA
-
依托单位:
Mechanisms of Steroid Resistance in Airway Smooth Muscle Cells
-
批准号:8010971
-
项目类别:
-
资助金额:$24.8万
-
财政年份:2007
-
负责人:OMAR TLIBA
-
依托单位:
海外基金